| Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease NN Andersen, B Pasternak, S Basit, M Andersson, H Svanström, ... Jama 311 (23), 2406-2413, 2014 | 283 | 2014 |
| Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome N Pedersen, NN Andersen, Z Végh, L Jensen, DV Ankersen, M Felding, ... World Journal of Gastroenterology: WJG 20 (43), 16215, 2014 | 239 | 2014 |
| Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study J Kirchgesner, L Beaugerie, F Carrat, NN Andersen, T Jess, ... Gut 67 (7), 1261-1268, 2018 | 127 | 2018 |
| Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study NN Andersen, B Pasternak, N Friis-Møller, M Andersson, T Jess bmj 350, 2015 | 112 | 2015 |
| Has the risk of colorectal cancer in inflammatory bowel disease decreased? NN Andersen, T Jess World journal of gastroenterology: WJG 19 (43), 7561, 2013 | 112 | 2013 |
| eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease N Pedersen, M Elkjaer, D Duricova, J Burisch, C Dobrzanski, ... Alimentary pharmacology & therapeutics 36 (9), 840-849, 2012 | 112 | 2012 |
| Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet N Pedersen, Z Vegh, J Burisch, L Jensen, DV Ankersen, M Felding, ... World Journal of Gastroenterology: WJG 20 (21), 6680, 2014 | 94 | 2014 |
| Risk of infections associated with biological treatment in inflammatory bowel disease NN Andersen, T Jess World Journal of Gastroenterology: WJG 20 (43), 16014, 2014 | 71 | 2014 |
| Inflammatory bowel disease and risk of coronary heart disease C Rungoe, NN Andersen, T Jess Trends in cardiovascular medicine 25 (8), 699-704, 2015 | 63 | 2015 |
| Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study J Kirchgesner, NN Andersen, F Carrat, T Jess, L Beaugerie Gut 69 (5), 852-858, 2020 | 55 | 2020 |
| Comparison of infliximab and adalimumab in biologic-naive patients with ulcerative colitis: a nationwide Danish cohort study S Singh, NN Andersen, M Andersson, EV Loftus Jr, T Jess Clinical Gastroenterology and Hepatology 15 (8), 1218-1225. e7, 2017 | 50 | 2017 |
| Risk of cardiovascular disease in inflammatory bowel disease NN Andersen, T Jess World journal of gastrointestinal pathophysiology 5 (3), 359, 2014 | 43 | 2014 |
| Tolerability of FODMAP–reduced diet in irritable bowel syndrome–efficacy, adherence, and body weight course T Frieling, J Heise, B Krummen, C Hundorf, S Kalde Zeitschrift für Gastroenterologie 57 (06), 740-744, 2019 | 30 | 2019 |
| Reduced risk of UC in families affected by appendicitis: a Danish national cohort study NN Andersen, S Gørtz, M Frisch, T Jess Gut 66 (8), 1398-1402, 2017 | 29 | 2017 |
| Comparison of infliximab with adalimumab in 827 biologic‐naive patients with Crohn's disease: a population‐based Danish cohort study S Singh, NN Andersen, M Andersson, EV Loftus Jr, T Jess Alimentary Pharmacology & Therapeutics 47 (5), 596-604, 2018 | 26 | 2018 |
| Autoimmune diseases in microscopic colitis: A Danish nationwide case–control study S Wildt, LK Munck, M Winther‐Jensen, T Jess, N Nyboe Andersen Alimentary Pharmacology & Therapeutics 54 (11-12), 1454-1462, 2021 | 22 | 2021 |
| Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: a Danish Crohn Colitis Database study NN Andersen, S Caspersen, T Jess, P Munkholm Journal of Crohn's and Colitis 2 (4), 304-309, 2008 | 22 | 2008 |
| The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection D Ward, S Gørtz, MT Ernst, NN Andersen, SK Kjær, J Hallas, ... European Respiratory Journal 59 (4), 2022 | 20 | 2022 |
| Differences in epidemiological features between ulcerative colitis and Crohn’s disease: the early life-programmed versus late dysbiosis hypothesis L Beaugerie, E Langholz, N Nyboe-Andersen, B Pigneur, H Sokol, ... Medical hypotheses 115, 19-21, 2018 | 16 | 2018 |
| Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors NN Andersen, B Pasternak, M Andersson, NM Nielsen, T Jess JAMA internal medicine 175 (12), 1990-1992, 2015 | 16* | 2015 |
